BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6305166)

  • 1. Effects of kallikrein on human platelet aggregation.
    Ohde H; Mozai T; Hase M; Kitakoji J; Ninomiya F; Chung YH; Fujimoto M
    Adv Exp Med Biol; 1983; 156 (Pt B)():741-5. PubMed ID: 6305166
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibitory effect of kallikrein on ristocetin-induced platelet aggregation (author's transl)].
    Fukutake K; Ukita M; Kitamura T; Yamaguchi I
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):549-50. PubMed ID: 495016
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of the 3',5'-cyclic phosphates of 2-methylthioadenosine, 2-chloroadenosine and adenosine on platelet aggregation.
    Maguire MH; Penglis-Caredes F; Gough GR
    Experientia; 1974 Aug; 30(8):922-4. PubMed ID: 4369976
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of adenosine-diphosphate- and collagen-induced platelet aggregation in vitro by UW solution.
    Himmelreich G; Riess H
    Transplant Proc; 1991 Jun; 23(3):1939-40. PubMed ID: 2063433
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of platelet aggregation by moxalactam and free N-methylthiotetrazole.
    Ingalls CS; Somani P; Freimer EH
    Clin Ther; 1989; 11(5):640-51. PubMed ID: 2629724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of platelet activation on the agglutination of platelets by von Willebrand factor.
    Mills DC; Hunchak K; Karl DW; Kirby EP
    Mol Pharmacol; 1990 Feb; 37(2):271-7. PubMed ID: 2154674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effect of losartan on platelet aggregation in patients with hypertension.
    Akdemir R; Ozhan H; Yazici M; Gunduz H; Duran S; Gurel C; Ozdas S; Uyan C; Basar I; Ulutin T
    Heart Vessels; 2004 Jul; 19(4):167-71. PubMed ID: 15278389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mycophenolate mofetil and mycophenolic acid on platelet aggregation in vitro.
    Malyszko J; Malyszko JS; Mysliwiec M
    Transplant Proc; 2000 Sep; 32(6):1347-9. PubMed ID: 10995975
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of platelet aggregation using the KZM-1-R meter (aggregation inducers: ADP, collagen, ristocetin, ristomycin, adrenaline. Therapy control by use of acetylsalicylic acid)].
    Stepanauskas M; Norden C; Söllner P; Heine H
    Z Med Lab Diagn; 1981; 22(3):148-54. PubMed ID: 6270924
    [No Abstract]   [Full Text] [Related]  

  • 10. ADP, ristocetin, bovine factor VII and thrombasthenic platelets.
    Miragliotta G; Remuzzi G; Minetti B; de Gaetano G
    Thromb Haemost; 1976 Aug; 36(1):286-8. PubMed ID: 1036823
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Visual micromethod for determining thrombocyte aggregation activity in the presence of different aggregating agents].
    Shitikova AS
    Lab Delo; 1984; (4):215-20. PubMed ID: 6202940
    [No Abstract]   [Full Text] [Related]  

  • 13. Opposite effect of lysine on platelet aggregation induced by arachidonate and by other aggregants.
    Ts'ao C; Hart SJ; Krajewski DV; Sorensen PG
    Thromb Haemost; 1982 Aug; 48(1):78-83. PubMed ID: 6813998
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of endothelin-1 on aggregation of normal and uremic platelets.
    Pawlak K; Małyszko JS; Małyszko J; Myśliwiec M
    Pol J Pharmacol; 1996; 48(2):185-90. PubMed ID: 9112649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
    Haslam RJ; Rosson GM
    Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet count ratio (PCR) as an additional parameter in the quantitation of platelet aggregation in vitro.
    Benner KU; Tamblyn CH; Swank RL; Seaman GV
    Thromb Res; 1980 Mar; 17(6):801-8. PubMed ID: 7404488
    [No Abstract]   [Full Text] [Related]  

  • 17. Surface-immobilized prostaglandin as a platelet protective agent.
    Grode GA; Pitman J; Crowley JP; Leininger RI; Falb RD
    Trans Am Soc Artif Intern Organs; 1974; 20A():38-41. PubMed ID: 4375330
    [No Abstract]   [Full Text] [Related]  

  • 18. [Assessment of speed of an anti-platelet effect after two different doses of acetylsalicylic acid by flocculation].
    Malý M; Vojácek J; Hadacová I; Mates M; Hájek P; Durdil V
    Vnitr Lek; 2004 Jun; 50(6):428-33. PubMed ID: 15346635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibition of platelet agglutination and aggregation by aromatic amidino compounds.
    Geratz JD; Tidwell RR; Brinkhous KM; Mohammad SF; Dann O; Loewe H
    Thromb Haemost; 1978 Apr; 39(2):411-25. PubMed ID: 580990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of kallikrein on lung metastasis of cancer cells, and its influence on platelet aggregation].
    Kawai Y
    Nihon Gan Chiryo Gakkai Shi; 1985 May; 20(4):765-75. PubMed ID: 3850923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.